T-CELL/HISTIOCYTE RICH LYMPHOMA
Clinical trials for T-CELL/HISTIOCYTE RICH LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL/HISTIOCYTE RICH LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL/HISTIOCYTE RICH LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SGR-1505 enters early human testing for B-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called SGR-1505 in about 98 adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to find the safest dose and understand side effects. Participants must have measurable disease and be well enough for dail…
Matched conditions: T-CELL/HISTIOCYTE RICH LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
New CAR T-Cell therapy SynKIR-310 enters first human trial for Tough-to-Treat lymphoma
Disease control Recruiting nowThis early-phase study tests a new treatment called SynKIR-310 for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment uses a patient's own immune cells, modified to target and attack cancer cells. The main go…
Matched conditions: T-CELL/HISTIOCYTE RICH LYMPHOMA
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC